These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab. Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058 [TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study. Daruich A; Matet A; Schalenbourg A; Zografos L Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Finger PT; Chin KJ; Semenova EA Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167 [TBL] [Abstract][Full Text] [Related]
14. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study. Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098 [TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma. Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123 [TBL] [Abstract][Full Text] [Related]
17. PARAFOVEAL CAPILLARY DENSITY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA: Analysis of Eyes Without Radiation Maculopathy. Say EA; Samara WA; Khoo CT; Magrath GN; Sharma P; Ferenczy S; Shields CL Retina; 2016 Sep; 36(9):1670-8. PubMed ID: 27232466 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma. Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029 [TBL] [Abstract][Full Text] [Related]
19. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy. Bakri SJ; Larson TA Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series. Subrayan V; Khaw KW; Peyman M; Koay AC; Tajunisah I Ophthalmologica; 2013; 229(4):208-11. PubMed ID: 23548379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]